Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 571,453 | 508,745 | 516,777 | 471,197 | 570,557 |
| Cost of Goods | 256,755 | 229,276 | 236,545 | 207,168 | 262,042 |
| Gross Profit | 314,698 | 279,469 | 280,232 | 264,029 | 308,515 |
| Operating Expenses | 336,080 | 251,652 | 258,252 | 238,470 | 249,074 |
| Operating Income | -20,627 | 28,093 | 22,525 | 25,727 | 59,483 |
| Interest Expense | 6,534 | 5,634 | 5,632 | 5,580 | 6,034 |
| Other Income | -1,026 | 229 | 9,971 | 48 | 749 |
| Pre-tax Income | -28,187 | 22,688 | 26,864 | 20,195 | 54,198 |
| Income Tax | -5,492 | 4,283 | 8,850 | 7,919 | 8,570 |
| Net Income Continuous | -22,695 | 18,405 | 18,014 | 12,276 | 45,628 |
| Net Income | $-22,695 | $18,405 | $18,014 | $12,276 | $45,628 |
| EPS Basic Total Ops | -0.78 | 0.63 | 0.61 | 0.42 | 1.56 |
| EPS Basic Continuous Ops | -0.77 | 0.63 | 0.61 | 0.42 | 1.56 |
| EPS Diluted Total Ops | -0.77 | 0.62 | 0.61 | 0.42 | 1.54 |
| EPS Diluted Continuous Ops | -0.77 | 0.62 | 0.61 | 0.42 | 1.55 |
| EBITDA(a) | $-20,627 | $66,581 | $60,103 | $59,817 | $59,483 |